End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.26 BGN | +1.95% | +1.95% | +9.44% |
Feb. 29 | Sopharma AD Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Sopharma AD Reports Sales Results for the Month and Eleven Months Ended November 2023 | CI |
Sales 2024 * | 1.99B 1.1B | Sales 2025 * | - | Capitalization | 1.12B 622M |
---|---|---|---|---|---|
Net income 2024 * | 72M 39.95M | Net income 2025 * | - | EV / Sales 2024 * | 0.56 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
13.6
x | P/E ratio 2025 * |
-
| Employees | 4,721 |
Yield 2024 * |
4.79% | Yield 2025 * |
-
| Free-Float | 30.85% |
1 day | +1.95% | ||
1 week | +1.95% | ||
1 month | +5.03% | ||
3 months | -1.57% | ||
6 months | -11.83% | ||
Current year | +9.44% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 40 | 00-09-30 | |
Director of Finance/CFO | - | 01-12-31 | |
Ivaylo Mechev
ADM | Chief Administrative Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 40 | 00-09-30 | |
Bisera Lazarova
BRD | Director/Board Member | - | - |
Director/Board Member | 61 | 99-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 6.26 | +1.95% | 6,741 |
24-05-30 | 6.14 | +0.33% | 3,035 |
24-05-29 | 6.12 | -0.97% | 2,625 |
24-05-28 | 6.18 | +2.66% | 4,276 |
End-of-day quote Bulgaria S.E., May 30, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+9.44% | 622M | |
-37.88% | 13.99B | |
-31.97% | 10.67B | |
-20.28% | 6.75B | |
+12.54% | 6.29B | |
-11.51% | 5.88B | |
+75.00% | 4.96B | |
-2.92% | 4.61B | |
-9.20% | 3.74B | |
-19.40% | 3.16B |
- Stock Market
- Equities
- SFA Stock